In turn, the Asian Cancer Research Group (ACRG) reported four molecular subtypes of GC with clinical significance based on mRNA expression profiles: microsatellite-stable (MSS)/TP53-, MSS/TP53+, MSI, and epithelial-to- mesenchymal transition (EMT) subtypes. Here, TP53 is linked to cancer.